Initial treatment of uninsured patients with ST-elevation myocardial infarction by facility percutaneous coronary intervention capabilities.


Journal

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
ISSN: 1553-2712
Titre abrégé: Acad Emerg Med
Pays: United States
ID NLM: 9418450

Informations de publication

Date de publication:
Feb 2024
Historique:
revised: 26 10 2023
received: 16 06 2023
accepted: 27 10 2023
pmc-release: 01 02 2025
medline: 26 2 2024
pubmed: 3 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

Timely reperfusion is necessary to reduce morbidity and mortality in patients with ST-elevation myocardial infarction (STEMI). Initial care by facilities with percutaneous coronary intervention (PCI) capabilities reduces time to reperfusion. We sought to examine whether insurance status was associated with initial care at emergency departments (EDs) with PCI capabilities among adult patients with STEMI. We conducted a retrospective cross-sectional study using Department of Healthcare Access and Information, a nonpublic statewide database reporting ED visits and hospitalizations in California. We included adults initially arriving at EDs with STEMI by diagnostic code (International Classification of Diseases Ninth Revision or 10th Revision) from 2011 to 2019. Multivariable logistic regression modeling included initial care by PCI capable facility as the primary outcome and insurance status (none vs. any) as the primary exposure. Covariates included patient, facility, and temporal factors and we conducted multiple robustness checks. We analyzed 135,358 eligible visits with STEMI included. In our multivariable model, the odds of uninsured patients being initially treated at a PCI-capable facility were significantly lower than those of insured patients (adjusted odds ratio 0.62, 95% CI 0.54-0.72, p < 0.001) and was unchanged in sensitivity analyses. Uninsured patients with STEMI had significantly lower odds of first receiving care at facilities with PCI capabilities. Our results suggest potential disparities in accessing high-quality and time-sensitive treatment for uninsured patients with STEMI.

Sections du résumé

BACKGROUND BACKGROUND
Timely reperfusion is necessary to reduce morbidity and mortality in patients with ST-elevation myocardial infarction (STEMI). Initial care by facilities with percutaneous coronary intervention (PCI) capabilities reduces time to reperfusion. We sought to examine whether insurance status was associated with initial care at emergency departments (EDs) with PCI capabilities among adult patients with STEMI.
METHODS METHODS
We conducted a retrospective cross-sectional study using Department of Healthcare Access and Information, a nonpublic statewide database reporting ED visits and hospitalizations in California. We included adults initially arriving at EDs with STEMI by diagnostic code (International Classification of Diseases Ninth Revision or 10th Revision) from 2011 to 2019. Multivariable logistic regression modeling included initial care by PCI capable facility as the primary outcome and insurance status (none vs. any) as the primary exposure. Covariates included patient, facility, and temporal factors and we conducted multiple robustness checks.
RESULTS RESULTS
We analyzed 135,358 eligible visits with STEMI included. In our multivariable model, the odds of uninsured patients being initially treated at a PCI-capable facility were significantly lower than those of insured patients (adjusted odds ratio 0.62, 95% CI 0.54-0.72, p < 0.001) and was unchanged in sensitivity analyses.
CONCLUSIONS CONCLUSIONS
Uninsured patients with STEMI had significantly lower odds of first receiving care at facilities with PCI capabilities. Our results suggest potential disparities in accessing high-quality and time-sensitive treatment for uninsured patients with STEMI.

Identifiants

pubmed: 37921055
doi: 10.1111/acem.14831
pmc: PMC11025473
mid: NIHMS1983347
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-128

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL114822
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21HL140382
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL134182
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21 HL140382
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024975
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL114822
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134182
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States

Informations de copyright

© 2023 by the Society for Academic Emergency Medicine.

Références

Medicine (Baltimore). 2016 Aug;95(32):e4554
pubmed: 27512881
N Engl J Med. 2013 Sep 5;369(10):901-9
pubmed: 24004117
J Bone Joint Surg Am. 2007 Dec;89(12):2625-31
pubmed: 18056494
Am J Cardiol. 2015 Jan 15;115(2):167-70
pubmed: 25465931
Med Care. 2014 Aug;52(8):720-7
pubmed: 25023917
J Am Coll Cardiol. 2008 Jun 24;51(25):2442-3
pubmed: 18565404
JAMA Netw Open. 2023 Jun 1;6(6):e2317831
pubmed: 37294567
JAMA Netw Open. 2020 Nov 2;3(11):e2025874
pubmed: 33196809
Health Serv Res. 2003 Oct;38(5):1359-72
pubmed: 14596395
Am J Cardiol. 2016 Aug 1;118(3):332-7
pubmed: 27282834
J Am Coll Cardiol. 2012 Nov 13;60(20):2017-31
pubmed: 23083784
Am Heart J. 2011 Jan;161(1):76-83.e1
pubmed: 21167337
Am J Emerg Med. 2016 May;34(5):767-71
pubmed: 26926589
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):659-67
pubmed: 24192572
JAMA Netw Open. 2021 Sep 1;4(9):e2123389
pubmed: 34468755
J Am Coll Cardiol. 2004 May 19;43(10):1755-62
pubmed: 15145095
Ann Emerg Med. 2014 May;63(5):561-571.e8
pubmed: 24342815
J Pediatr Surg. 2016 Dec;51(12):2048-2052
pubmed: 27686481
JAMA. 2011 Jun 22;305(24):2540-7
pubmed: 21693742
Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):468-75
pubmed: 20682917
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):14-20
pubmed: 22147882
JAMA Netw Open. 2020 Apr 1;3(4):e203890
pubmed: 32352526
JACC Cardiovasc Interv. 2017 Mar 13;10(5):438-447
pubmed: 28216215
Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):948-957
pubmed: 32193943
West J Emerg Med. 2017 Oct;18(6):1010-1017
pubmed: 29085531
Crit Pathw Cardiol. 2013 Jun;12(2):43-4
pubmed: 23680806

Auteurs

Sara Lin (S)

Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Andrew Shermeyer (A)

Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.

Sayeh Nikpay (S)

Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.

Renee Y Hsia (RY)

Department of Emergency Medicine, University of California at San Francisco, San Francisco, California, USA.
Philip R. Lee Institute for Health Policy Studies, University of California at San Francisco, San Francisco, California, USA.

Michael J Ward (MJ)

Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Geriatric Research, Education, and Clinical Center (GRECC), VA Tennessee Valley Healthcare System, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH